Welcome to our dedicated page for F5 SEC filings (Ticker: FFIV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on F5's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into F5's regulatory disclosures and financial reporting.
F5, Inc. filed an 8-K announcing two items. First, it issued a press release covering financial results for the fourth quarter ended September 30, 2025, attached as Exhibit 99.1 and not treated as filed under the Exchange Act. Second, the Board determined that CEO and President François Locoh-Donou will also become Chair of the Board following the next Annual Meeting of Shareholders, expected in March 2026. Current Chair Alan J. Higginson will retire, and the Board will appoint a lead independent director at that time.
F5, Inc. reported a cybersecurity incident involving a highly sophisticated nation-state actor that gained long-term access to certain systems, including the BIG-IP product development environment and engineering knowledge platform. The company says containment actions have been successful and has not observed new unauthorized activity since initiating its response. Some files were exfiltrated, including portions of BIG-IP source code and information about undisclosed vulnerabilities the company was working on. F5 states it is not aware of undisclosed critical or remote code vulnerabilities or active exploitation, and independent experts validated no modification to its software supply chain.
F5 reports no evidence of access to CRM, financial, support case management, or iHealth systems; there is also no evidence of access to NGINX, Distributed Cloud Services, or Silverline. The U.S. Department of Justice permitted delayed disclosure on September 12, 2025. As of this disclosure, operations have not been materially impacted, and the financial impact is being evaluated. Separately, Michael Montoya resigned from the Board on October 9, 2025, and became Chief Technology Operations Officer effective October 13, 2025; the Board size is now ten members.
Locoh-Donou Francois, who serves as President, CEO & Director of F5, Inc. (FFIV), reported a sale of 1,300 shares of the company's common stock on 10/01/2025 at a reported price of $320.61 per share. After the transaction, Mr. Locoh-Donou beneficially owned 107,553 shares directly and 42,000 shares indirectly through a family trust. The filing indicates the sale was executed pursuant to a Rule 10b5-1 trading plan dated 11/13/2024. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 10/03/2025. The document contains only the disclosed insider sale and current beneficial ownership figures.
Form 144 notice reports a proposed sale of 1,300 common shares by Francois Locoh-Donou through Morgan Stanley Smith Barney on NASDAQ, with an aggregate market value of $416,793.00. The issuer’s outstanding shares are listed as 57,447,170. The shares to be sold were originally acquired as restricted stock: 252 shares on 05/01/2021 and 1,048 shares on 02/01/2021. The filing also discloses two recent sales by the same person in the past three months: 1,300 shares on 09/02/2025 for $402,493.00 and 1,300 shares on 08/01/2025 for $400,582.00. The notice includes the required certification that the seller is not aware of undisclosed material adverse information.
F5, Inc. announced that it has entered into an acquisition arrangement with Calypso AI Corp, a Delaware corporation. Under this agreement, and subject to its stated terms and conditions, Calypso AI will become a direct, wholly owned subsidiary of F5.
The announcement was made through a press release furnished as Exhibit 99.1 under Item 7.01 of a current report. The press release and related information are being furnished, not filed, which means they are not automatically subject to certain Exchange Act liability provisions or incorporation by reference into other documents unless specifically stated.
F5, Inc. (FFIV) Form 4 summary — The reporting person, Schramm Lyra Amber, identified as Chief People Officer, reported a sale of 2,701 shares of F5 common stock on 09/08/2025 at a price of $316.57 per share. The filing states the transaction was executed pursuant to a Rule 10b5-1 trading plan dated 06/09/2025. Following the reported disposition the filing shows 0 shares beneficially owned. The Form 4 was signed by Angelique M. Okeke by power of attorney on 09/09/2025. This disclosure records an officer-initiated sale under a pre-established plan; no additional financial results, forward guidance, or other transactions are included in this filing.
Form 144 filed for F5, Inc. (FFIV) shows a proposed sale of 2,701 common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $855,055.57. The filing lists three tranches of restricted stock acquired from the issuer on 02/01/2025 (200 shares), 05/01/2025 (2,291 shares), and 08/01/2025 (210 shares), all paid on their acquisition dates. No securities were reported sold in the prior three months. The filer certifies they are not aware of undisclosed material adverse information. The notice documents the intent to sell shares by an individual for whose account the securities were issued and identifies the executing broker and approximate sale date of 09/08/2025.
Locoh-Donou Francois, President, CEO & Director of F5, Inc. (FFIV), reported a sale of 1,300 shares of common stock on 09/02/2025 at a price of $309.61 per share. After the sale, he beneficially owned 108,853 shares directly and 42,000 shares indirectly through a family trust. The Form 4 indicates the sale was executed pursuant to a Rule 10b5-1 trading plan dated 11/13/2024. The filing was signed by an authorized representative by power of attorney on 09/04/2025.
Form 144 notice indicates proposed sale of 1,300 common shares by an officer/person for whose account the securities are to be sold, to be executed through Morgan Stanley Smith Barney LLC on 09/02/2025 with an aggregate market value of $402,493.00. The filing shows the 1,300 shares were acquired as restricted stock on 02/01/2021 (589 shares) and 11/01/2022 (711 shares). The issuer’s outstanding shares are listed as 57,447,170. The filing also discloses two prior common-stock sales by the same person: 1,300 shares on 08/01/2025 for $400,582.00 and 1,300 shares on 07/01/2025 for $382,616.00. The signer represents they are not aware of undisclosed material adverse information and includes the standard criminal-misstatement warning.
Chad Michael Whalen, EVP Worldwide Sales of F5, Inc. (FFIV), reported multiple open-market sales executed under a Rule 10b5-1 trading plan dated April 30, 2025. The filing shows four sales on 08/11/2025 totaling 5,297 shares, with weighted-average sale prices running from $320.24 to $323.07 per share.
Those entries in Table I show the reporting person’s direct beneficial ownership declining across the transactions to a reported holding of 23,591 shares following the sales. The filing notes the transactions were made pursuant to the pre-established 10b5-1 plan and provides weighted-price ranges for transparency.